Congress Proposes $2 Million Daily Fines for Drug Makers Blocking Discounts to Health Clinics
This bill is currently sitting in the House Committee on Energy and Commerce. It has not seen any action since July 2025, which means it has been stalled for about 11 months. The committee must choose to review the bill before it can move any further in the legislative process.
No action since July 2025
This bill’s path across every version that has carried it.
How this policy affects specific groups of people
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Sen. Peter Welch is introducing the 340B PATIENTS Act to clarify that providers can access discounted drugs through contract pharmacies. The bill seeks to resolve a perennial source of friction between drugmakers and hospitals by codifying the right to use outside pharmacies for distribution.

The 340B PATIENTS Act, reintroduced by Rep. Doris Matsui and Sen. Peter Welch, would prohibit manufacturers from conditioning the provision of 340B-priced drugs on the location or method of dispensing, specifically protecting contract pharmacy arrangements from industry restrictions.
A bipartisan group of senators is hammering out legislation to reform the 340B drug discount program. While hospitals push for protections like the PATIENTS Act to codify contract pharmacies, drugmakers argue for more guardrails to ensure discounts directly benefit low-income patients.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
340B PATIENTS Act of 2025
Analysis generated by AI. Always verify with official sources.